Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$64,000.00

New Strategies for the Synthesis of Medicinally Relevant Small Molecules

EF 2024-25

Résumé
The desire to efficiently and safely prepare value-added organic molecules from simple building blocks remains a key driving force in the chemical industry and has shaped the field of organic synthesis in recent decades. The transformation of chemical building blocks into medicines or fine chemicals typically requires numerous synthetic steps, leading to an increase in manufacturing costs and the production of chemical waste. The reagents used in these transformations and the waste that is generated may also be toxic or corrosive, leading to additional complications for reaction set-up, waste disposal and product purification. My research program focuses on developing enabling synthetic methods to access medicinally relevant small molecules in a more efficient (e.g. less waste, fewer steps) and/or safer (e.g. non-toxic reagents/waste) manner. In particular, our recent efforts have focused on the development of new methods to prepare and functionalize cyclopropane- and nitrile-containing molecules given the importance of these substrate classes in the pharmaceutical and agrochemical industries. The research that will be proposed in this NSERC Discovery Grant application will focus on using the expertise we have gained over the last 5 years to develop new enabling technologies for synthetic organic chemists. We will maximize impact on our recent discoveries in the area of Ni-catalysis involving 1-electron chemistry to develop 1) a broad scope of reductive cyanation reactions and 2) cross-coupling reactions involving C(sp3)-O electrophiles. Furthermore, as pioneers of the use of electrophilic homoenolates, we will exploit these reagents for the synthesis of small 3- and 4-membered rings. Throughout this program, we will focus on target selection, to ensure we are preparing molecules of high interest to research end-users (e.g. industrial chemists), and mechanistic studies, to enable new catalyst/reagent design and the exploration of new chemical reactivity.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2021-03533
Name nom
Rousseaux, Sophie
Department département
Department of Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
New Strategies for the Synthesis of Medicinally Relevant Small Molecules
Keywords
catalysis; nickel; cyclopropanes; homoenolates; radical cross-coupling; reductive cross-coupling; nitriles; cyclopropylamines; transnitrilation; mechanistic studies
Application summary
The desire to efficiently and safely prepare value-added organic molecules from simple building blocks remains a key driving force in the chemical industry and has shaped the field of organic synthesis in recent decades. The transformation of chemical building blocks into medicines or fine chemicals typically requires numerous synthetic steps, leading to an increase in manufacturing costs and the production of chemical waste. The reagents used in these transformations and the waste that is generated may also be toxic or corrosive, leading to additional complications for reaction set-up, waste disposal and product purification. My research program focuses on developing enabling synthetic methods to access medicinally relevant small molecules in a more efficient (e.g. less waste, fewer steps) and/or safer (e.g. non-toxic reagents/waste) manner. In particular, our recent efforts have focused on the development of new methods to prepare and functionalize cyclopropane- and nitrile-containing molecules given the importance of these substrate classes in the pharmaceutical and agrochemical industries. The research that will be proposed in this NSERC Discovery Grant application will focus on using the expertise we have gained over the last 5 years to develop new enabling technologies for synthetic organic chemists. We will maximize impact on our recent discoveries in the area of Ni-catalysis involving 1-electron chemistry to develop 1) a broad scope of reductive cyanation reactions and 2) cross-coupling reactions involving C(sp3)-O electrophiles. Furthermore, as pioneers of the use of electrophilic homoenolates, we will exploit these reagents for the synthesis of small 3- and 4-membered rings. Throughout this program, we will focus on target selection, to ensure we are preparing molecules of high interest to research end-users (e.g. industrial chemists), and mechanistic studies, to enable new catalyst/reagent design and the exploration of new chemical reactivity.